Skip to content

Reviewing the Effectiveness of Balloon Catheter Treatment for Hardening of the Arteries in the Legs

A Retrospective Study on the Efficacy of Percutaneous Transluminal Angioplasty in the Treatment of Lower Extremity Arteriosclerosis Obliterans

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600121853
Enrollment
Unknown
Registered
2026-04-03
Start date
2026-04-03
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lower extremity arteriosclerosis obliterans (ASO)

Interventions

Observation group:None

Sponsors

Peking University Third Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Patients diagnosed with lower extremity arteriosclerosis obliterans (ASO) who were hospitalized in the Department of Interventional Radiology and Vascular Surgery, Peking University Third Hospital, between January 1, 2000, and December 31, 2025; 2.Patients meeting the clinical diagnosis of lower extremity ASO, confirmed by imaging examinations (including color Doppler ultrasound, CTA, or DSA); 3.Patients who underwent percutaneous transluminal angioplasty (PTA) at our center; 4.Patients aged = 18 years; 5.Patients with complete medical records available for pre-operative, post-operative, and follow-up data;

Exclusion criteria

Exclusion criteria: 1.Patients treated for non-atherosclerotic lesions, such as acute limb ischemia, arterial embolism, or vasculitis; 2.Patients who received treatments other than PTA, including open surgery or amputation; 3.Patients with critical missing data in medical records, making evaluation impossible;

Design outcomes

Primary

MeasureTime frame
primary patency;

Secondary

MeasureTime frame
Technical Success Rate;Ankle-BrachialIndex Improvement;

Countries

China

Contacts

Public ContactXiangui Zhang

Peking University Third Hospital

drzhangxg@pku.edu.cn+86 10 8226 6699

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026